Literature DB >> 30775071

Stereotactic radiosurgery and fractionated stereotactic radiosurgery for vestibular schwannomas: A comparison of clinical outcomes from the RSSearch patient registry.

Raj Singh1, Hayden Ansinelli1, Jan Jenkins2, Joanne Davis2, Sanjeev Sharma3,4, John Austin Vargo5.   

Abstract

PURPOSE: To compare clinical outcomes following stereotactic radiosurgery (SRS) and fractionated stereotactic radiosurgery (fSRS) for vestibular schwannomas (VS). MATERIALS/
METHODS: We identified 64 VS patients from the RSSearch Patient Registry (12 treated with SRS and 52 patients treated with fSRS). Potential factors predictive of local control (LC) and toxicity were estimated using the Kaplan-Meier method, Cox proportional hazards model, and binary logistic regressions with propensity score weighting.
RESULTS: SRS (100%) and fSRS (94.2%) resulted in similar LC (p = 0.33). fSRS was associated with a higher likelihood of experiencing toxicities (42.3% vs. 8.3%; p = 0.054 on time-to-event analysis) that was maintained following a propensity-score weighted binary logistic regression (p = 0.037) and propensity-score weighted Cox regression (p = 0.039; hazard ratio (HR) = 8.85 (95% CI: 1.1 - 70.1)).
CONCLUSION: In a multi-institutional analysis, we note equivalent LC but higher toxicity with fSRS compared to SRS for VS.

Entities:  

Keywords:  Toxicity; acoustic neuroma; hypofractionation; registry; stereotactic radiosurgery; vestibular schwannoma

Year:  2019        PMID: 30775071      PMCID: PMC6355446     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  21 in total

1.  Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study.

Authors:  O W M Meijer; W P Vandertop; J C Baayen; B J Slotman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

Review 2.  Role of cell cycle in mediating sensitivity to radiotherapy.

Authors:  Timothy M Pawlik; Khandan Keyomarsi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

3.  Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.

Authors:  Christine Collen; Ben Ampe; Thierry Gevaert; Maarten Moens; Nadine Linthout; Mark De Ridder; Dirk Verellen; Jean D'Haens; Guy Storme
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-12       Impact factor: 7.038

4.  The prevalence of "incidental" acoustic neuroma.

Authors:  Doris Lin; Joseph L Hegarty; Nancy J Fischbein; Robert K Jackler
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-03

5.  Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution.

Authors:  D W Andrews; O Suarez; H W Goldman; M B Downes; G Bednarz; B W Corn; M Werner-Wasik; J Rosenstock; W J Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-08-01       Impact factor: 7.038

6.  Descriptive epidemiology of vestibular schwannomas.

Authors:  Jennifer M Propp; Bridget J McCarthy; Faith G Davis; Susan Preston-Martin
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

Review 7.  Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery.

Authors:  A Niranjan; L D Lunsford; J C Flickinger; A Maitz; D Kondziolka
Journal:  Neurosurgery       Date:  1999-10       Impact factor: 4.654

8.  Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.

Authors:  Hideyuki Kano; Douglas Kondziolka; Aftab Khan; John C Flickinger; L Dade Lunsford
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

9.  Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.

Authors:  Bethany M Anderson; Deepak Khuntia; Søren M Bentzen; Heather M Geye; Lori L Hayes; John S Kuo; Mustafa K Baskaya; Behnam Badie; Amar Basavatia; G Mark Pyle; Wolfgang A Tomé; Minesh P Mehta
Journal:  J Neurooncol       Date:  2013-10-20       Impact factor: 4.130

10.  Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma.

Authors:  Masahiro Morimoto; Yasuo Yoshioka; Tadayuki Kotsuma; Kana Adachi; Hiroya Shiomi; Osamu Suzuki; Yuji Seo; Masahiko Koizumi; Naoki Kagawa; Manabu Kinoshita; Naoya Hashimoto; Kazuhiko Ogawa
Journal:  Jpn J Clin Oncol       Date:  2013-06-17       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.